The invitation to tender serves to conclude agreements with pharmaceutical companies within the meaning of section 130a (8) of the Social Code (SGB) Fifth Book (V) (hereinafter: discount agreements or discount agreement) with
a duration of 24 calendar months for prescription drugs and pharmacy-only medicines that do not require a prescription. According to § 130a (8) sentence 1 SGB V, the invitation to tender is only available to pharmaceutical entrepreneurs or
Bidding consortia of pharmaceutical companies within the meaning of § 4 (18) of the German Medicines Act (AMG). It is already made clear that for lots 001 to 075 framework agreements with three tenderers, for lots 076 to 098 framework agreements with two tenderers and
for lots 099 to 123, framework agreements may be concluded with a tenderer.
In this case, a consortium is considered to be one bidder. Further details can be found in the tender documents.
Active ingredient: acetylsalicylic acid, Type of prescription: pharmacy, Dosage form: KTA, TAB, TMR, GRA in bag, ATC code: B01AC06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: candesartan and hydrochlorothiazide, Prescription type: prescription, Dosage form: TAB, ATC code: C09DA06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: colecalciferol, Prescription type: prescription, Dosage form: WKA, ATC code: A11CC05Framework agreements are concluded with an economic operator for lots 099 to 123.
Wirkstoff: Darunavir, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: J05AE10Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: diclofenac, type of prescription: prescription, dosage form: SUP, ATC code: M01AB05Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: estriol, Prescription type: prescription, Dosage form: OVU, ATC code: G03CA04Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: formoterol, Prescription: prescription, Dosage form: IHP, ATC code: R03AC13Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: Glatiramer, Prescription: prescription, Dosage form: FER, ATC code: L03AX13Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: glibenclamide, Prescription type: prescription, Dosage form: TAB, ATC code: A10BB01Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: ibandronic acid, Type of prescription: prescription, Dosage form: FTA, ATC code: M05BA06Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: ibandronic acid, type of prescription: prescription, dosage form: IFK, ATC code: M05BA06Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: isosorbide mononitrate, type of prescription: prescription, dosage form: RED, REK, RET, ATC code: C01DA14Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: carvedilol, Prescription: prescription, Dosage form: FTA, TAB, ATC code: C07AG02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: isosorbide mononitrate, type of prescription: prescription, dosage form: TAB, ATC code: C01DA14Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: lamivudine, Prescription type: prescription, Dosage form: FTA, ATC code: J05AF05Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: lanreotide, type of prescription: prescription, dosage form: ILO, ATC code: H01CB03Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: mesalazine, Type of prescription: prescription, Dosage form: RGR in sachet, RGR in sachet msr., RET, ATC code: A07EC02Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: mometasone, Prescription type: prescription, Dosage form: CRE, ATC code: D07AC13Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: mometasone, Prescription type: prescription, Dosage form: LOE, ATC code: D07AC13Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: mometasone, Prescription type: prescription, Dosage form: SAL, ATC code: D07AC13Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: morphine, Prescription type: prescription, Dosage form: FTA, HKP, ATC code: N02AA01Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: ofloxacin, prescription type: prescription, dosage form: AUS, ATC code: S01AE01Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: propafenone, Prescription type: prescription, Dosage form: FTA, TAB, UTA, ATC code: C01BC03Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: chlormadinone and ethinyl estradiol, type of prescription: prescription, dosage form: FTA, ATC code: G03AA15Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Rupatadin, Prescription: prescription, Dosage form: TAB, ATC code: R06AX28Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: Salbutamol, Prescription type: prescription, Dosage form: LOV - solution for inhalation, ATC code: R03AC02Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: Triamcinolone acetonide, Prescription type: prescription, Dosage form: CRE, ATC code: D07AB09Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: venlafaxine, Prescription type: prescription, Dosage form: FTA, TAB, ATC code: N06AX16Framework agreements are concluded with an economic operator for lots 099 to 123.
Active ingredient: ciprofloxacin, prescription type: prescription, dosage form: FTA, ATC code: J01MA02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: citalopram, type of prescription: prescription, dosage form: FTA, ATC code: N06AB04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: clopidogrel, Prescription type: prescription, Dosage form: FTA, ATC code: B01AC04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Diclofenac, Verschreibungsart: verschreibungspflichtig, Darreichungsform: BTA, FTA, HKP, HKM, TMR, PSE, TSE, UTA, WKA, ATC-Code: M01AB05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: diclofenac, prescription type: prescription, dosage form: RED, REC, REK fast, SL-REC, RET, RET fast, ATC code: M01AB05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: dienogest and ethinyl estradiol, type of prescription: prescription, dosage form: FTA, TAB, UTA, ATC code: G03AA16Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Enalapril, Prescription type: prescription, Dosage form: TAB, ATC code: C09AA02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Alendronsäure, Verschreibungsart: verschreibungspflichtig, Darreichungsform: BTA, FTA, TAB, ATC-Code: M05BA04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Entecavir, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: J05AF10Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Erlotinib, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: L01EB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ezetimibe, prescription type: prescription, dosage form: TAB, ATC code: C10AX09Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ezetimibe and simvastatin, type of prescription: prescription, dosage form: TAB, ATC code: C10BA02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Febuxostat, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: M04AA03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: fentanyl, Prescription: prescription, Dosage form: PFT, ATC code: N02AB03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: formoterol, Prescription type: prescription, Dosage form: HPI, ATC code: R03AC13Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: furosemide, type of prescription: prescription, dosage form: TAB, ATC code: C03CA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: gabapentin, type of prescription: prescription, dosage form: FTA, HKP, ATC code: N03AX12Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: glimepiride, Prescription type: prescription, Dosage form: TAB, ATC code: A10BB12Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Allopurinol, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, UTA, ATC-Code: M04AA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Hydrochlorothiazide, Prescription type: prescription, Dosage form: TAB, ATC code: C03AA03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ibandronic acid, Prescription: prescription, Dosage form: ILO, ATC code: M05BA06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first- and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer for that lot will be discounted and awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid ultimately follows in the 2-partner model.
Wirkstoff: Ibuprofen, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, KTA, TAB, KAP, UTA, SMT, Weichgelatinekapseln, ATC-Code: M01AE01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ibuprofen, Prescription type: pharmacy only, Dosage form: SUE, SIR, ATC code: M01AE01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Lisinopril, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, ATC-Code: C09AA03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Losartan, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: C09CA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first- and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer for that lot will be discounted and awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid ultimately follows in the 2-partner model.
Active ingredient: losartan and hydrochlorothiazide, type of prescription: prescription, dosage form: FTA, ATC code: C09DA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Memantin, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, SMT, ATC-Code: N06DX01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: mesalazine, Prescription type: prescription, Dosage form: SUP, ATC code: A07EC02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: mesalazine, type of prescription: prescription, dosage form: TMR, ATC code: A07EC02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ambrisentan, type of prescription: prescription, dosage form: FTA, ATC code: C02KX02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: metamizole, type of prescription: prescription, dosage form: FTA, TAB, ATC code: N02BB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active substance: metamizole, Prescription: prescription, Dosage form: LSE, TEI, LOE, ATC code: N02BB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: metformin, Prescription type: prescription, Dosage form: FTA, TAB, ATC code: A10BA02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Metoprolol succinate, Prescription type: prescription, Dosage form: RET, ATC code: C07AB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Metoprolol tartrat, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, LTA, TAB, ATC-Code: C07AB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Metoprolol tartrate, Prescription type: prescription, Dosage form: RET, ATC code: C07AB02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: mirtazapine, Prescription type: prescription, Dosage form: FTA, SMT, ATC code: N06AX11Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Montelukast, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, ATC-Code: R03DC03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: morphine, Prescription type: prescription, Dosage form: REK, RET, Application frequency 2 x daily, ATC code: N02AA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: moxonidine, Prescription type: prescription, Dosage form: FTA, ATC code: C02AC05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: amlodipine, type of prescription: prescription, dosage form: TAB, ATC code: C08CA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Mycophenolat mofetil, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, HKP, TAB, ATC-Code: L04AA06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first- and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer for that lot will be discounted and awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid ultimately follows in the 2-partner model.
Active ingredient: ofloxacin, Prescription type: prescription, Dosage form: ATR, ATC code: S01AE01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: omeprazole, Prescription type: prescription, Dosage form: HKM, KAP, KMR, MRP in KAP, TMR, ATC code: A02BC01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active substance: oxycodone, Prescription type: prescription, Dosage form: FTA, HKP, ATC code: N02AA05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: oxycodone, Prescription type: prescription, Dosage form: RET, ATC code: N02AA05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: pantoprazole, Prescription type: prescription, Dosage form: TMR, ATC code: A02BC02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first- and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer for that lot will be discounted and awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid ultimately follows in the 2-partner model.
Wirkstoff: Pravastatin, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, TAB, ATC-Code: C10AA03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Prednisolone, Prescription type: prescription, Dosage form: TAB, ATC code: H02AB06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: propiverine, Prescription type: prescription, Dosage form: FTA, UTA, ATC code: G04BD06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: quetiapine, type of prescription: prescription, dosage form: RET, ATC code: N05AH04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: amoxicillin, Prescription type: prescription, Dosage form: FTA, TAB, Oblong tablets, ATC code: J01CA04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ramipril, Prescription type: prescription, Dosage form: FTA, HKP, KAP, TAB, ATC code: C09AA05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: ramipril and hydrochlorothiazide, type of prescription: prescription, dosage form: FTA, TAB, ATC code: C09BA05Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Risperidon, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, SMT, SMF, ATC-Code: N05AX08Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Rosuvastatin, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: C10AA07Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: simvastatin, Prescription type: prescription, Dosage form: FTA, ATC code: C10AA01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Wirkstoff: Sitagliptin, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, ATC-Code: A10BH01Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: sitagliptin and metformin, type of prescription: prescription, dosage form: FTA, ATC code: A10BD07Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: tamsulosin, Prescription type: prescription, Dosage form: RET, ICP retaded, HVW, ATC code: G04CA02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Topiramate, Prescription type: prescription, Dosage form: FTA, HKP, ATC code: N03AX11Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first- and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer for that lot will be discounted and awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid ultimately follows in the 2-partner model.
Active ingredient: Torasemide, Prescription: prescription, Dosage form: TAB, ATC code: C03CA04Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: bicalutamide, Prescription type: prescription, Dosage form: FTA, ATC code: L02BB03Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: tramadol, type of prescription: prescription, dosage form: FTA, HKP, TAB, ATC code: N02AX02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: tramadol, prescription type: prescription, dosage form: HKP retarded, RET (application 2 x daily), ATC code: N02AX02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: tramadol, type of prescription: prescription, dosage form: LSE, TEI, LOE, ATC code: N02AX02Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: venlafaxine, Type of prescription: prescription, Dosage form: HKP retarded, RET, ATC code: N06AX16Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: zoledronic acid, Prescription: prescription, Dosage form: INF, ATC code: M05BA08Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: zonisamide, Prescription type: prescription, Dosage form: HKP, ATC code: N03AX15Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active substance: Artovastatin and ezetimibe, Prescription type: prescription, Dosage form: FTA, HKP, TAB, ATC code: C10BA05Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: bisoprolol and hydrochlorothiazide, Prescription type: prescription, Dosage form: FTA, TAB, ATC code: C07BB07Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: cinacalcet, type of prescription: prescription, dosage form: FTA, ATC code: H05BX01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: colecalciferol, type of prescription: pharmacy, dosage form: TAB, ATC code: A11CC05Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Bisoprolol, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, LTA, TAB, ATC-Code: C07AB07Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: Dimethyl fumarate, Prescription type: prescription, Dosage form: HKM, ATC code: L04AX07Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: dronedarone, type of prescription: prescription, dosage form: FTA, ATC code: C01BD07Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: enalapril and hydrochlorothiazide, type of prescription: prescription, dosage form: TAB, ATC code: C09BA02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: latanoprost and timolol, type of prescription: prescription, dosage form: ATR, ATC code: S01ED51Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: levodopa and carbidopa, type of prescription: prescription, dosage form: RET, ATC code: N04BA02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: levodopa and carbidopa, prescription type: prescription, dosage form: TAB, ATC code: N04BA02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: levonorgestrel and ethinyl estradiol, type of prescription: prescription, dosage form: FTA, ATC code: G03AA07Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: levonorgestrel and ethinyl estradiol, type of prescription: prescription, dosage form: UTA, ATC code: G03AA07Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: mesalazine, Prescription: prescription, Dosage form: RSC, ATC code: A07EC02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: metoclopramide, Prescription type: prescription, Dosage form: FTA, KAP, TAB, ATC code: A03FA01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: candesartan, Prescription type: prescription, Dosage form: TAB, ATC code: C09CA06Framework agreements are concluded with 3 economic operators for lots 001 to 075.
If the difference in savings between the potential first-place and second-placed offers of a lot for the lots in the 3-partner model is greater than 40%, then the respective second and third placed offer with respect to that lot will fall out of the classification and the bid will ultimately be awarded in the 1-partner model.
If the difference in savings between the second and third placed offers of a lot for the lots in the 3-partner model is greater than 40%, the respective third-placed offer with respect to that lot falls out of the classification and the bid is ultimately awarded in the 2-partner model.
Active ingredient: morphine, Type of prescription: prescription, Dosage form: ILO, ATC code: N02AA01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: ofloxacin, Prescription type: prescription, Dosage form: ATR (single-dose pipettes), ATC code: S01AE01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: raloxifene, Prescription type: prescription, Dosage form: FTA, ATC code: G03XC01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active substance: rosuvastatin and ezetimibe, type of prescription: prescription, dosage form: FTA, TAB, ATC code: C10BA06Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: salbutamol, type of prescription: prescription, dosage form: DOS, ATC code: R03AC02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: Salbutamol, Prescription type: prescription, Dosage form: LOV - Ready inhalate, ATC code: R03AC02Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Verapamil, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, LTA, UTA, ATC-Code: C08DA01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: verapamil, type of prescription: prescription, dosage form: REC, RET, ATC code: C08DA01Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Wirkstoff: Zolmitriptan, Verschreibungsart: verschreibungspflichtig, Darreichungsform: FTA, SMT, TAB, ATC-Code: N02CC03Framework agreements are concluded with 2 economic operators for lots 076 to 098.
If, for the lots in the 2-partner model, the difference in savings between the potentially eligible first- and second-placed offers of a lot is greater than 40%, then the respective second-placed offer with regard to this lot falls out of the evaluation and the
The contract is ultimately awarded in the 1-partner model.
Active ingredient: colecalciferol, Prescription type: prescription, Dosage form: TEI, ATC code: A11CC05Framework agreements are concluded with an economic operator for lots 099 to 123.